Join the 'Oxybutynin' group to help and get support from people like you. How it works
Oxybutynin Blog
| Tweet |
Urinary Incontinence Drugs May Be More Trouble Than They're Worth
Posted 9 Apr 2012 by Drugs.com
MONDAY, April 9 – For women with urinary incontinence, the available treatments may cause more problems than they solve and many stop taking the medications because of side effects that can include dry mouth and constipation, a new analysis indicates. Urge incontinence is marked by frequent, sudden urges to urinate that can result in leakage and accidents. Standard treatment includes lifestyle changes, pelvic floor exercises, bladder training and/or medication. There are several types of medications that may be used alone or together for the condition. Generally, these medications relax bladder contractions and help improve bladder function. Researchers from the University of Minnesota School of Public Health analyzed data from 94 studies to see how well the available drugs worked. A given medication was deemed effective if women achieved a 50 percent or more reduction in daily ... Read more
Related support groups: Overactive Bladder, Urinary Incontinence, VESIcare, Oxybutynin, Detrol, Ditropan, Toviaz, Detrol LA, Gelnique, Solifenacin, Tolterodine, Oxytrol, Ditropan XL, Anturol, Fesoterodine
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
Posted 8 Dec 2011 by Drugs.com
PARSIPPANY, N.J. and EWING, N.J., Dec. 8, 2011 /PRNewswire/ – Watson Pharmaceuticals, Inc. and Antares Pharma, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Antares' topical oxybutynin gel 3% product for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and frequency. OAB is a condition that affects more than 33 million Americans, and the market currently exceeds $2.0 billion annually. Antares' oxybutynin product is a clear, odorless topical gel available in a convenient, metered-dose pump that has demonstrated to be an effective and safe treatment for overactive bladder (OAB). Because the active ingredient is delivered transdermally, it is not metabolized by the liver in the same way as orally administered oxybutynin. This results in a low level of side effects, such as dry mouth and constipation. ... Read more
Related support groups: Overactive Bladder, Oxybutynin
Some People With Alzheimer's Take Conflicting Drugs
Posted 28 Oct 2011 by Drugs.com
FRIDAY, Oct. 28 – Many Alzheimer's patients who take cholinesterase inhibitors to slow their brain disease also take drugs that counter the effects of those Alzheimer's medications, a new study says. Clinical trials have shown that cholinesterase inhibitors such as Aricept (donepezil) have a modest impact on the functional and cognitive decline caused by Alzheimer's disease, noted the researchers at the Group Health Research Institute in Seattle. "Cholinesterase inhibitors are today's primary therapy for slowing Alzheimer's disease," study leader Denise Boudreau said in an institute news release. "Anticholinergic properties are often found in drugs commonly used to treat gastrointestinal disorders, allergies, urinary incontinence, depression and Parkinson's disease, and they can have negative effects on cognition and function in the elderly. There's concern that if someone is taking ... Read more
Related support groups: Benadryl, Aricept, Diphenhydramine, Alzheimer's Disease, Meclizine, Oxybutynin, Dramamine, Cogentin, Benztropine, Exelon, Ditropan, Scopolamine, Donepezil, Bonine, Artane
Ask a Question
Further Information
Related Condition Support Groups
Overactive Bladder, Urinary Incontinence, Dysuria, Hyperhidrosis, Prostatitis
Related Drug Support Groups
Ditropan, Gelnique, Ditropan XL, Oxytrol, Urotrol, Anturol